PubRank

Hans Wilhelm Doerr

Author PubWeight™ 112.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003 27.97
2 Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol 2003 4.66
3 Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain. Clin Chem 2006 2.32
4 Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol 2009 1.65
5 Phylogeny of the SARS coronavirus. Science 2003 1.56
6 Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra. J Clin Microbiol 2002 1.42
7 Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol 2003 1.39
8 Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med 2006 1.34
9 Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3. Cancer Res 2009 1.34
10 Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett 2007 1.20
11 Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med 2003 1.13
12 Valproic acid as anti-cancer drug. Curr Pharm Des 2007 1.11
13 Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother 2007 1.11
14 Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med 2004 1.11
15 Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol 2007 1.10
16 Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochem Pharmacol 2009 1.09
17 Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J Virol 2005 1.08
18 SARS molecular detection external quality assurance. Emerg Infect Dis 2004 1.08
19 Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. PLoS One 2011 1.06
20 Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression. J Infect Dis 2002 1.05
21 Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. J Virol 2004 1.03
22 Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol 2009 1.03
23 First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion 2009 1.02
24 Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma. Cancer Res 2003 0.99
25 Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples. J Clin Virol 2005 0.99
26 Molecular assays for monitoring HIV infection and antiretroviral therapy. Expert Rev Mol Diagn 2007 0.98
27 Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells. Neoplasia 2010 0.97
28 Comparison of nine resistance interpretation systems for HIV-1 genotyping. Antivir Ther 2003 0.96
29 Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies. Virology 2007 0.95
30 Novel approach for genotyping varicella-zoster virus strains from Germany. J Clin Microbiol 2007 0.95
31 Infection of human retinal pigment epithelial cells with influenza A viruses. Invest Ophthalmol Vis Sci 2009 0.94
32 West Nile virus infection induces interferon signalling in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2006 0.93
33 Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo. Int J Oncol 2006 0.93
34 NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method. Biochem Biophys Res Commun 2005 0.92
35 Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med Microbiol Immunol 2009 0.92
36 Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness. Neoplasia 2004 0.92
37 Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol 2010 0.91
38 Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis. Neoplasia 2005 0.91
39 Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol 2003 0.91
40 Evaluation of the LiPA HIV-1 RT assay version 1: comparison of sequence and hybridization based genotyping systems. J Clin Virol 2002 0.91
41 Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus. Med Microbiol Immunol 2009 0.91
42 Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition. Invest Ophthalmol Vis Sci 2005 0.90
43 HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem Biophys Res Commun 2004 0.90
44 The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication. Cell Mol Life Sci 2010 0.90
45 Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in Lesotho. Sex Transm Dis 2010 0.89
46 HBV reactivation after kidney transplantation. J Clin Virol 2005 0.89
47 Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells. Neoplasia 2008 0.89
48 Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D. J Clin Microbiol 2007 0.88
49 Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame. PLoS One 2012 0.87
50 Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. J Med Chem 2006 0.87
51 Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells. Med Microbiol Immunol 2009 0.86
52 Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine 2010 0.86
53 Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation. Med Res Rev 2005 0.86
54 Role of interferons in the treatment of severe acute respiratory syndrome. Expert Opin Biol Ther 2004 0.86
55 Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res 2005 0.85
56 Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid. Biochem Pharmacol 2004 0.85
57 Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions. J Clin Virol 2008 0.84
58 Impact of persistent cytomegalovirus infection on human neuroblastoma cell gene expression. Biochem Biophys Res Commun 2005 0.84
59 Detection and quantitation of HBV DNA in miniaturized samples: multi centre study to evaluate the performance of the COBAS ® AmpliPrep/COBAS ® TaqMan ® hepatitis B virus (HBV) test v2.0 by the use of plasma or serum specimens. J Virol Methods 2010 0.84
60 Problems and challenges in the diagnosis of vertical infection with human cytomegalovirus (CMV): lessons from two accidental cases. J Clin Virol 2011 0.84
61 Of chickens and men: avian influenza in humans. Curr Mol Med 2009 0.84
62 In vitro replication of varicella-zoster virus in human retinal pigment epithelial cells. J Clin Microbiol 2008 0.83
63 [Varicella and herpes zoster. Part 1: virology, epidemiology, clinical picture, laboratory diagnostics]. Med Klin (Munich) 2010 0.83
64 A novel immunomodulatory mechanism of ribavirin in suppressing natural killer cell function. Biochem Pharmacol 2009 0.83
65 A 10-year molecular survey of herpes simplex virus type 1 in Germany demonstrates a stable and high prevalence of genotypes A and B. J Clin Virol 2009 0.82
66 High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells. Int J Mol Med 2005 0.82
67 Novel approach to differentiate subclades of varicella-zoster virus genotypes E1 and E2 in Germany. Virus Res 2009 0.81
68 Ribavirin inhibits angiogenesis by tetrahydrobiopterin depletion. FASEB J 2006 0.81
69 Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV. Antivir Ther 2007 0.81
70 The human eye (retina): a site of persistent HCMV infection? Graefes Arch Clin Exp Ophthalmol 2005 0.81
71 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells. Biochem Pharmacol 2002 0.80
72 Effects of S-acetylglutathione in cell and animal model of herpes simplex virus type 1 infection. Med Microbiol Immunol 2003 0.80
73 Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation. J Clin Virol 2005 0.80
74 Thrombin stimulates IL-6 and IL-8 expression in cytomegalovirus-infected human retinal pigment epithelial cells. Int J Mol Med 2004 0.80
75 The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β. Biochem Pharmacol 2010 0.79
76 Dengue in travellers is still underestimated. Intervirology 2008 0.79
77 Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells. Cardiovasc Res 2007 0.79
78 Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages. Med Microbiol Immunol 2010 0.78
79 Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. Chem Biodivers 2008 0.78
80 [Viral gastroenteritis. An epidemiologic investigation between the period 2001-2006]. Med Klin (Munich) 2008 0.78
81 Phytochemical analysis and in vitro evaluation of the biological activity against herpes simplex virus type 1 (HSV-1) of Cedrus libani A. Rich. Phytomedicine 2007 0.78
82 Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells. Med Microbiol Immunol 2003 0.78
83 Flow cytometric analysis of virus-specific T lymphocytes: practicability of detection of HCMV-specific T lymphocytes in whole blood in patients after stem cell transplantation. J Immunol Methods 2006 0.77
84 A 12-year molecular survey of clinical herpes simplex virus type 2 isolates demonstrates the circulation of clade A and B strains in Germany. J Clin Virol 2010 0.77
85 Molecular analysis of varicella-zoster virus strains circulating in Tanzania demonstrating the presence of genotype M1. J Clin Microbiol 2008 0.77
86 Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol 2008 0.77
87 Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis. Med Microbiol Immunol 2012 0.77
88 Evaluation of carcinogenic potential of two nitro-musk derivatives, musk xylene and musk tibetene in a host-mediated in vivo/in vitro assay system. Anticancer Res 2003 0.77
89 [Varicella and herpes zoster. Part 2: therapy and prevention]. Med Klin (Munich) 2010 0.76
90 Virology and epidemiology of oral herpesvirus infections. Med Microbiol Immunol 2002 0.75
91 Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV-1-infected patients and healthy controls. HIV Clin Trials 2013 0.75
92 Clinical course and laboratory parameters of the first Dobrava-Belgrade hantavirus infection imported to Germany. J Clin Virol 2008 0.75
93 Durability of protective antibody titres is not enhanced by a two-dose schedule of an ASO3-adjuvanted pandemic H1N1 influenza vaccine in adult HIV-1-infected patients. Scand J Infect Dis 2014 0.75
94 The complexity of aging: cancer risk among elderly people and infectious risk among those with cancer. Anticancer Agents Med Chem 2013 0.75
95 Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method. Med Microbiol Immunol 2009 0.75
96 Measurements of HCV neutralizing antibodies and of HCV-specific CD4+ and CD8+ cells using hepatitis C virus pseudo-particles (HCVpp). J Clin Virol 2009 0.75
97 Supernatants from human cytomegalovirus (HCMV)-infected retinal glial cells increase transepithelial electrical resistance in a cell culture model: evidence of HCMV immune escape in the eye? Med Microbiol Immunol 2003 0.75
98 Docking studies reveal a selective binding of D-penicillamine to the transactivator protein of human immunodeficiency virus type 1. FEBS Lett 2002 0.75
99 [How dangerous is avian flu for mankind?]. Med Klin (Munich) 2005 0.75